Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

Mark A. Dawson(University of Cambridge), Rab K. Prinjha(GlaxoSmithKline (United Kingdom)), Antje Dittmann, George Giotopoulos(University of Cambridge), Marcus Bantscheff, Wai-In Chan(University of Cambridge), Samuel C. Robson(The Gurdon Institute), Chun‐wa Chung(GlaxoSmithKline (United Kingdom)), Carsten Hopf, Mikhail M. Savitski, Carola Huthmacher, Emma Gudgin(University of Cambridge), Dave Lugo(GlaxoSmithKline (United Kingdom)), Sören Beinke(GlaxoSmithKline (United Kingdom)), Trevor Chapman(GlaxoSmithKline (United Kingdom)), Emma J. Roberts(GlaxoSmithKline (United Kingdom)), Peter E. Soden(GlaxoSmithKline (United Kingdom)), Kurt R. Auger(South College), Olivier Mirguet(GlaxoSmithKline (France)), Konstanze Doehner(University Hospital Ulm), Ruud Delwel(Erasmus MC), Alan K. Burnett(Cardiff University), Philip D. Jeffrey(GlaxoSmithKline (United Kingdom)), Gerard Drewes, Kevin Lee(GlaxoSmithKline (United Kingdom)), Brian J.P. Huntly(University of Cambridge), Tony Kouzarides(The Gurdon Institute)
Nature
October 1, 2011
10.1038/nature10509
Cited by 1,518Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis